INTEGRATED BIOPHARMA INC (INBP) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
47/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseINBP / S&P -33.33% / 15.20% |
LoseINBP / S&P INBP unavailable / 15.00% |
LoseINBP / S&P INBP unavailable / 50.40% |
| 2026-Q10/3 |
LoseINBP / S&P -25.00% / -4.33% |
LoseINBP / S&P -8.83% / 11.30% |
LoseINBP / S&P -220.00% / 27.70% |
| 2025-Q41/3 |
WinINBP / S&P 24.14% / 2.65% |
LoseINBP / S&P -0.06% / 9.00% |
LoseINBP / S&P -125.00% / 13.40% |
| 2025-Q32/3 |
LoseINBP / S&P -19.44% / 8.12% |
WinINBP / S&P 4.72% / 4.61% |
WinINBP / S&P 50.00% / 13.45% |
| 2025-Q22/3 |
LoseINBP / S&P 5.88% / 10.94% |
WinINBP / S&P 8.02% / 4.83% |
WinINBP / S&P 300.00% / 10.63% |
| 2025-Q11/3 |
WinINBP / S&P 3.03% / -4.27% |
LoseINBP / S&P 4.67% / 4.98% |
LoseINBP / S&P INBP unavailable / 10.57% |
| 2024-Q41/3 |
WinINBP / S&P 43.48% / 2.41% |
LoseINBP / S&P 3.18% / 5.25% |
LoseINBP / S&P -500.00% / 6.15% |
| 2024-Q31/3 |
WinINBP / S&P 9.52% / 5.89% |
LoseINBP / S&P -0.47% / 5.89% |
LoseINBP / S&P -33.33% / 6.11% |
| 2024-Q20/3 |
LoseINBP / S&P -4.55% / 4.28% |
LoseINBP / S&P -0.70% / 5.38% |
LoseINBP / S&P -66.67% / 5.12% |
| 2024-Q10/3 |
LoseINBP / S&P -12.00% / 10.56% |
LoseINBP / S&P -0.75% / 5.71% |
LoseINBP / S&P -100.00% / 5.59% |
| 2023-Q40/3 |
LoseINBP / S&P -10.71% / 11.69% |
LoseINBP / S&P -5.54% / 6.81% |
LoseINBP / S&P -109.09% / 7.78% |
| 2023-Q30/3 |
LoseINBP / S&P -15.15% / -3.27% |
LoseINBP / S&P -8.17% / 7.52% |
LoseINBP / S&P -72.73% / -5.03% |
| 2023-Q20/3 |
LoseINBP / S&P -13.16% / 8.74% |
LoseINBP / S&P -9.91% / 9.50% |
LoseINBP / S&P -76.92% / -8.57% |
| 2023-Q11/3 |
WinINBP / S&P 8.57% / 7.50% |
LoseINBP / S&P -15.14% / 10.77% |
LoseINBP / S&P -63.64% / -15.69% |
| 2022-Q40/3 |
LoseINBP / S&P -20.45% / 7.56% |
LoseINBP / S&P -13.00% / 11.88% |
LoseINBP / S&P -52.17% / -17.99% |
| 2022-Q30/3 |
LoseINBP / S&P -12.00% / -4.88% |
LoseINBP / S&P -8.70% / 13.47% |
LoseINBP / S&P -54.17% / -1.41% |
| 2022-Q20/3 |
LoseINBP / S&P -36.71% / -16.10% |
LoseINBP / S&P -11.51% / 13.71% |
LoseINBP / S&P -48.00% / 11.04% |
| 2022-Q10/3 |
LoseINBP / S&P -24.04% / -4.60% |
LoseINBP / S&P 0.00% / 15.97% |
LoseINBP / S&P 29.41% / 42.23% |
| 2021-Q40/3 |
LoseINBP / S&P -0.95% / 11.03% |
LoseINBP / S&P 8.62% / 15.00% |
LoseINBP / S&P 43.75% / 96.40% |
| 2021-Q30/3 |
LoseINBP / S&P -4.55% / 0.58% |
LoseINBP / S&P 8.14% / 10.77% |
LoseINBP / S&P 60.00% / 69.42% |
| 2021-Q22/3 |
LoseINBP / S&P 5.77% / 8.55% |
WinINBP / S&P 20.45% / 6.58% |
WinINBP / S&P 92.31% / 51.81% |
| 2021-Q13/3 |
WinINBP / S&P 40.54% / 6.17% |
WinINBP / S&P 13.67% / -1.06% |
WinINBP / S&P 112.50% / 7.39% |
| 2020-Q43/3 |
WinINBP / S&P 57.45% / 12.15% |
WinINBP / S&P 6.23% / -3.72% |
WinINBP / S&P 100.00% / -33.42% |
| 2020-Q32/3 |
LoseINBP / S&P 4.44% / 8.93% |
WinINBP / S&P 10.68% / -2.04% |
WinINBP / S&P 150.00% / -27.10% |
| 2020-Q23/3 |
WinINBP / S&P 28.57% / 20.54% |
WinINBP / S&P 5.59% / -0.46% |
WinINBP / S&P 116.67% / -27.11% |
| 2020-Q13/3 |
WinINBP / S&P 40.00% / -19.60% |
WinINBP / S&P 7.88% / 3.47% |
WinINBP / S&P -0.00% / -14.75% |
| 2019-Q42/3 |
LoseINBP / S&P 4.17% / 9.07% |
WinINBP / S&P 17.23% / 5.36% |
WinINBP / S&P 33.33% / 2.99% |
| 2019-Q33/3 |
WinINBP / S&P 4.35% / 1.70% |
WinINBP / S&P 15.45% / 5.02% |
WinINBP / S&P 100.00% / 0.21% |
| 2019-Q23/3 |
WinINBP / S&P 64.29% / 4.30% |
WinINBP / S&P 14.34% / 6.64% |
WinINBP / S&P 500.00% / 8.65% |
| 2019-Q12/3 |
LoseINBP / S&P -6.67% / 13.65% |
WinINBP / S&P 15.49% / 8.12% |
WinINBP / S&P 100.00% / 14.29% |
| 2018-Q42/3 |
WinINBP / S&P 0.00% / -13.52% |
LoseINBP / S&P 7.00% / 9.05% |
WinINBP / S&P 50.00% / 18.23% |
| 2018-Q30/3 |
LoseINBP / S&P 0.00% / 7.71% |
LoseINBP / S&P 0.46% / 10.21% |
LoseINBP / S&P -50.00% / 19.06% |
| 2018-Q20/3 |
LoseINBP / S&P -11.76% / 3.43% |
LoseINBP / S&P -6.91% / 9.03% |
LoseINBP / S&P -90.00% / 14.46% |
| 2018-Q10/3 |
LoseINBP / S&P -5.56% / -0.76% |
LoseINBP / S&P -9.98% / 7.68% |
LoseINBP / S&P -50.00% / 12.46% |
| 2017-Q40/3 |
LoseINBP / S&P -18.18% / 6.64% |
LoseINBP / S&P -10.41% / 7.03% |
LoseINBP / S&P -42.86% / 13.82% |
| 2017-Q31/3 |
WinINBP / S&P 15.79% / 4.48% |
LoseINBP / S&P -3.09% / 5.68% |
LoseINBP / S&P -14.29% / 17.57% |
| 2017-Q22/3 |
LoseINBP / S&P -9.52% / 3.09% |
WinINBP / S&P 11.23% / 4.83% |
WinINBP / S&P 100.00% / 17.74% |
| 2017-Q12/3 |
LoseINBP / S&P -8.70% / 6.07% |
WinINBP / S&P 18.40% / 3.67% |
WinINBP / S&P 700.00% / 13.32% |
| 2016-Q42/3 |
WinINBP / S&P 53.33% / 3.82% |
WinINBP / S&P 23.22% / 2.09% |
LoseINBP / S&P INBP unavailable / 7.05% |
| 2016-Q33/3 |
WinINBP / S&P 36.36% / 3.85% |
WinINBP / S&P 18.51% / 0.20% |
WinINBP / S&P 600.00% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | INBP total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -26.92% | 20.78% |
| Annualized return | -26.92% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | INBP total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -80.00% | 83.14% |
| Annualized return | -27.52% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | INBP total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 111.11% | 319.30% |
| Annualized return | 7.76% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.